10-Q: Ensign Group Reports Strong Q3 Growth Amid Sector Expansion

The Ensign Group, Inc. announced significant revenue and earnings growth in Q3 2025, driven by strategic acquisitions and improved operational metrics across its skilled nursing and senior living facilities.

Summary

• Total revenue for the three months ended September 30, 2025, increased by $214.6 million, or 19.8%, to $1.296 billion, compared to the same period in 2024.
• Net income attributable to The Ensign Group, Inc. for Q3 2025 rose by 6.9% to $83.8 million, up from $78.4 million in Q3 2024.
• Diluted GAAP earnings per share increased by 6.0% to $1.42 for Q3 2025, compared to $1.34 in Q3 2024.
• For the nine months ended September 30, 2025, total revenue increased by $569.0 million, or 18.2%, to $3.697 billion.
• Net income attributable to The Ensign Group, Inc. for the nine months ended September 30, 2025, grew by 13.8% to $248.5 million, up from $218.3 million in the prior year.
• Diluted GAAP earnings per share for the nine months ended September 30, 2025, increased by 12.5% to $4.23, compared to $3.76 in the prior year.
• Overall occupancy percentage for skilled services increased by 1.4% to 82.3% in Q3 2025, with Same Facilities occupancy up 1.7% to 83.0% and Transitioning Facilities occupancy up 2.9% to 84.4%.
• Skilled mix by nursing days increased by 0.6% to 30.3% in Q3 2025, and by nursing revenue increased by 0.4% to 48.9%.
• The company expanded its operations with 34 new facilities (28 skilled nursing, 5 senior living, 1 campus operation) during the nine months ended September 30, 2025, adding 3,384 skilled nursing beds and 313 senior living units.
• Standard Bearer Healthcare REIT, Inc. (the company's captive REIT) added $228.9 million in real estate assets during the nine months ended September 30, 2025, including 15 skilled nursing, 1 senior living, and 2 campus operations.
• A $20.0 million stock repurchase program approved in February 2025 was fully utilized in Q1 and Q2 2025, and a new $20.0 million program was approved in May 2025, with no repurchases in Q3 2025.
• The company agreed to settle California wage, hour, or labor code-related class action violations for $12.0 million, pending court approval, for the six-year period ending December 2025.

Sentiment

Score: 8

Explanation: The company reported strong financial performance with significant revenue and earnings growth, driven by successful acquisitions and improved operational metrics like occupancy and skilled mix. The strategic expansion and active share repurchase programs are positive indicators. However, the extensive and complex regulatory environment, ongoing litigation, and inherent industry risks, while actively managed, present notable headwinds and uncertainties that temper an even higher score.

Positives

• Total revenue increased by 19.8% in Q3 2025 and 18.2% year-to-date, demonstrating strong top-line growth.
• Net income attributable to the company grew by 6.9% in Q3 2025 and 13.8% year-to-date, indicating healthy profitability.
• Diluted EPS increased by 6.0% in Q3 2025 and 12.5% year-to-date, reflecting improved shareholder value.
• Overall occupancy for skilled services increased to 82.3% in Q3 2025, with notable improvements in both Same Facilities (83.0%) and Transitioning Facilities (84.4%).
• Skilled mix by nursing days and revenue showed positive trends, indicating a shift towards higher acuity patients and better reimbursement rates.
• Strategic expansion into new states (Alabama, Alaska, Oregon) and the addition of 34 new operations during the nine months ended September 30, 2025, expands market footprint and growth opportunities.
• Standard Bearer REIT's acquisition of $228.9 million in real estate assets, including exercising purchase options, strengthens the company's owned real estate portfolio and provides an efficient vehicle for future growth.
• The company fully utilized a $20.0 million stock repurchase program in Q1 and Q2 2025 and approved another $20.0 million program, signaling confidence in its valuation and commitment to shareholder returns.
• Medicare daily rates at Same Facilities and Transitioning Facilities increased by 5.6% and 6.3% respectively, driven by market basket increases and a shift to higher acuity patients.
• Average Medicaid rates increased by 5.4% due to state reimbursement increases and participation in supplemental payment and quality improvement programs.

Negatives

• Cash and cash equivalents decreased from $464.6 million at December 31, 2024, to $443.7 million at September 30, 2025, primarily due to significant investing activities.
• Net cash used in investing activities increased substantially to $389.2 million for the nine months ended September 30, 2025, from $223.5 million in the prior year, reflecting high capital deployment for acquisitions and property/equipment purchases.
• Net cash used in financing activities increased to $12.6 million for the nine months ended September 30, 2025, from $0.8 million in the prior year, partly due to stock repurchases and increased dividend payments.
• The effective tax rate increased to 23.6% for the nine months ended September 30, 2025, from 22.0% in the prior year.
• The company is implementing a new ERP system, which involves significant complexity and risks of operational disruption, potential impact on financial reporting, and internal controls.
• General and administrative expense increased by 19.9% in Q3 2025 and 17.4% year-to-date, primarily due to additional headcount from acquisitions and increases in wages and benefits.

Risks

• Medicare and Medicaid rules, including reductions of reimbursement rates, changes to spending requirements, data reporting, measurement, and evaluation standards, could materially and adversely affect revenues, financial condition, and results of operations.
• State-level direct spending requirements for skilled nursing facilities (SNFs) could negatively impact operational results and increase the risk of non-compliance penalties.
• Changes to the U.S. healthcare system, including new regulations under the ACA, new transparency and disclosure requirements, and potential spending levels, continue to impose new requirements that could materially impact the business.
• Anticipated changes in the U.S. political environment, including those from the change in Presidential administration and control of Congress, and to regulatory agencies (particularly HHS), may result in significant changes to the regulatory framework, enforcement, and reimbursements.
• The company is subject to various government reviews, audits, and investigations (e.g., DOJ CID regarding Medicare/Texas Medicaid claims, OIG audits) that could lead to refund obligations, criminal charges, fines, sanctions, or loss of participation rights in Medicare/Medicaid programs.
• Extensive and complex laws and government regulations (licensure, quality of care, staffing, billing, fraud/abuse, HIPAA, antitrust) require significant expenditures or operational changes to maintain compliance.
• Public and government calls for increased enforcement efforts toward SNFs, enhanced penalties, and new guidance for surveyors could result in increased scrutiny, sanctions, and negative impacts on financial condition.
• CMS's changes to the Special Focus Facility (SFF) program, including a three-year look-back period, may increase the risk of facilities being subject to the program, fines, and sanctions even after graduation.
• Future cost containment initiatives by private third-party payors may limit revenue and profitability, potentially leading to reduced payment rates or loss of patients if contracts are not renewed.
• Reductions in Medicare Part B reimbursements for physician and non-physician services could impact reimbursement for medical professionals and adversely affect revenue.
• Increased investigation and enforcement activities related to HIPAA violations could lead to criminal penalties, civil sanctions, litigation, and costly remediation efforts.
• Security breaches and other cyber-security incidents could violate security laws, disrupt operations, lead to significant remediation costs, loss of confidential information, negative publicity, and regulatory penalties.
• The company may not be fully reimbursed for all services billed through consolidated billing, which could adversely affect revenue, financial condition, and results of operations.
• Increased competition for, or a shortage of, nurses and other skilled personnel could increase staffing and labor costs, lead to monetary fines for failing to meet minimum staffing requirements, or affect reimbursement.
• Annual caps, uncertainty regarding reimbursement, and other cost-reductions for outpatient therapy services may reduce future revenue and profitability or cause losses.
• State efforts to regulate or deregulate the healthcare services industry or the construction/expansion of facilities could impair growth or increase competition.
• Newly enacted state legislation (e.g., California's increased non-economic damages cap, ownership transparency laws) may affect litigation exposure and the broader regulatory environment.
• Changes to federal and state employment-related laws and regulations could increase the cost of doing business.
• Required regulatory approvals could delay or prohibit transfers of healthcare operations, resulting in periods of unreceived reimbursement.
• Compliance with federal and state fair housing, fire, safety, and other regulations may require unanticipated and costly expenditures.
• Revenue, financial condition, and results of operations could be negatively impacted by changes in patient acuity mix, payor mix, and payment methodologies.
• Litigation, including medical negligence, wage and hour class actions, and False Claims Act cases, could result in significant legal costs and large settlement amounts or damage awards.
• Internal investigations into care delivery, recordkeeping, and billing processes may detect noncompliance, leading to corrective actions that could decrease revenue.
• The California Office of Health Care Affordability (OHCA) Cost and Market Impact Review (CMIR) has the potential to delay or prevent proposed transactions and require disclosure of confidential information.
• Inability to complete future facility or business acquisitions at attractive prices or successfully integrate them could adversely affect revenue and operations.
• Acquisitions may expose the company to unforeseen costs, liabilities, and regulatory issues attributable to prior providers.
• Failure to achieve or maintain competitive quality of care ratings from CMS (Five-Star Quality Rating System) or private organizations could negatively affect business and referrals.
• Difficulty or increased cost in obtaining insurance, or risks associated with self-insurance programs, may expose the company to significant and unexpected costs and losses.
• Geographic concentration of independent subsidiaries (Arizona, California, Texas) leaves the company vulnerable to economic downturns, regulatory changes, or acts of nature in those areas.
• Actions by national labor unions, including negative publicity campaigns, may adversely affect revenue and profitability.
• Risks associated with leased property, including lease termination, extensions, and special charges, could adversely affect business and financial position.
• Failure to generate sufficient cash flow to cover required payments or meet operating covenants under long-term debt, mortgages, and operating leases could result in defaults and cross-defaults.
• A housing downturn could decrease demand for senior living services, impacting occupancy rates and revenues.
• Expansion into other relevant healthcare industries may subject the company to risks in markets with limited prior experience.
• If referral sources fail to view the company as an attractive skilled nursing provider or refer fewer patients, the patient base may decrease.
• Need for additional capital to fund growth may not be obtainable on acceptable terms, limiting growth strategies.
• Delays in reimbursement from government or commercial payors may cause liquidity problems.
• Continued use and growth of managed care organizations (MCOs) may contribute to delays or reductions in reimbursement, including Managed Medicaid.
• Compliance with Department of Housing and Urban Development (HUD) regulations may require unanticipated expenditures.
• Failure to safeguard patient trust funds could lead to reimbursement obligations, citations, fines, and penalties.
• Reliance on multiple independent subsidiaries as a holding company structure means liabilities of one subsidiary could be imposed on the parent or other subsidiaries.
• Standard Bearer's failure to qualify as a REIT could result in substantial tax liability, and legislative actions affecting REITs could have a negative effect.
• Failure to comply with existing environmental laws could result in increased expenditures, litigation, and potential loss of business and asset value.

Future Outlook

The company anticipates continued healthy growth in revenue and overall results by diligently working with existing and recently acquired operations to reach their full clinical and financial potential. The operating model, which empowers local operators, is expected to continue delivering positive trends in turnover and agency usage. Future acquisitions of turnaround or start-up operations are expected to result in lower initial occupancy rates and skilled mix, which will vary based on the type of facilities acquired. The company believes its current cash balances, cash flow from operations, and available borrowing capacity will be sufficient to cover operating needs for at least the next 12 months, with approximately $180.0 million budgeted for renovation projects in 2025. The company will continue to monitor and advocate against adverse federal, state, and local regulatory developments.

Management Comments

• We believe we exist to dignify and transform post-acute care.
• Our dedication to our cultural and operational fundamentals continues to deliver strong results.
• Our strength remains in our operating model, which empowers each operator to form their own market-specific strategy and adjust to the needs of their local medical communities.
• We anticipate minimal impact on our businesses as both Medicare and Medicaid are mandatory health program payments that continue even during a lapse of appropriations (federal government shutdown).
• We expect the REIT structure to allow us to better demonstrate the growing value of our owned real estate and provide us with an efficient vehicle for future acquisitions of properties.
• Historically, we have generally experienced lower occupancy rates and lower skilled mix at Recently Acquired Facilities and therefore, we anticipate lower overall occupancy during years of growth.
• We anticipate more states may face challenging choices regarding their state budgets, which will increase the risk of lower SNF reimbursement rates.

Industry Context

The post-acute care industry is experiencing significant regulatory changes and increased scrutiny, particularly from federal and state governments regarding Medicare and Medicaid reimbursement, staffing standards, and ownership transparency. The enactment of the One Big Beautiful Bill (OBBB) introduces substantial reforms to Medicaid financing and eligibility, potentially reducing state flexibility and increasing the risk of lower SNF reimbursement rates. While the federal government's minimum staffing standards rule faces strong opposition and legislative hurdles, the overall regulatory environment remains complex and dynamic. The industry is also grappling with labor shortages and rising costs, which are partially offset by a shift towards higher acuity patients and strategic acquisitions. Cybersecurity threats are a growing concern across the healthcare sector. The company's strategy of acquiring underperforming facilities and integrating them into its operational model, coupled with its captive REIT structure, positions it to navigate these challenges and capitalize on market opportunities.

Comparison to Industry Standards

• The company's overall occupancy rate of 82.3% in Q3 2025 for skilled services is strong, especially considering the integration of recently acquired facilities which typically have lower initial occupancy rates. This compares favorably to industry averages, which often fluctuate based on regional demand and competitive landscapes.
• The 6.0% increase in diluted EPS for Q3 2025 and 12.5% year-to-date demonstrates robust earnings growth, potentially outperforming many peers in the highly regulated skilled nursing and senior living sectors, where margins can be tight due to reimbursement pressures.
• The 19.8% revenue growth in Q3 2025 and 18.2% year-to-date is indicative of aggressive and successful expansion through acquisitions, which is a key differentiator in a fragmented industry. This growth rate likely exceeds that of many organic-growth-focused competitors.
• The company's strategic use of a captive REIT (Standard Bearer) for real estate acquisitions and management provides a unique structure compared to many operators who solely lease or own properties directly, offering potential efficiencies and valuation benefits similar to larger healthcare REITs like Welltower or Ventas, but within a captive model.
• The company's ability to increase Medicare daily rates by 5.6% and 6.3% in Same and Transitioning Facilities, respectively, and Medicaid rates by 5.4%, suggests effective management of payor mix and acuity levels, potentially outperforming competitors struggling with stagnant or declining reimbursement rates.
• The extensive detailing of regulatory risks and litigation, including specific CIDs and settlements, highlights the inherent challenges in the post-acute care industry. While the company is actively managing these, the volume of such disclosures is typical for large operators in this highly scrutinized sector, such as Genesis Healthcare or Kindred Healthcare, which also face similar regulatory and legal pressures.

Management Changes

Corporate Governance

Legal Proceedings

• Agreed to settle substantially all alleged wage, hour, or labor code-related violations asserted on a class or representative basis against independent subsidiaries in California for $12.0 million, pending court approval, for the six-year period ending December 2025.
• Received a Civil Investigative Demand (CID) from the U.S. Department of Justice (DOJ) in January 2024, investigating whether claims have been submitted to Medicare and Texas Medicaid for unnecessary services from January 1, 2016, to the present. The company is cooperating, but the outcome and potential impact are unknown.
• A jury returned a verdict against one of the independent subsidiaries in a four-week medical negligence trial in Arizona in late November 2023; the company is in the process of appealing the verdict.
• Settled a civil case for $48.0 million in 2024 (accrued as of December 31, 2023) related to a 2018 DOJ CID and subsequent qui tam complaint concerning alleged False Claims Act (FCA) and Anti-Kickback Statute (AKS) violations regarding relationships with medical directors. The matter is resolved without admissions of wrongdoing.
• The California Office of Health Care Affordability (OHCA) is conducting a Cost and Market Impact Review (CMIR) regarding a proposed transaction involving several California operations, and issued an investigatory subpoena on October 10, 2025, for confidential documents. This process has the potential to delay or prevent transactions.

Related Party Transactions

• Standard Bearer Healthcare REIT, Inc. (captive REIT) has intercompany master lease agreements with certain of the company's independent subsidiaries, generating intercompany rental revenue of $27.6 million for Q3 2025 and $78.3 million for YTD Sep 2025.
• The Service Center provides management services to Standard Bearer, generating intercompany management fees of $1.955 million for Q3 2025 and $5.530 million for YTD Sep 2025.
• Standard Bearer has intercompany debt arrangements with The Ensign Group, Inc., resulting in interest expense of $9.090 million for Q3 2025 and $25.153 million for YTD Sep 2025.
• The Pennant Group, Inc. (Pennant), with which certain directors also serve, leases 32 senior living operations from the company, generating rental income of $4.084 million for Q3 2025 and $12.288 million for YTD Sep 2025.

Stakeholder Impact

• Shareholders benefit from increased diluted EPS ($1.42 in Q3 2025, $4.23 YTD Sep 2025) and ongoing stock repurchase programs, indicating management's confidence and commitment to returning capital.
• Employees are impacted by additional headcount due to acquisition activities and increases in wages and benefits, reflecting enhanced performance and growth, but also face labor market disequilibrium and potential staffing shortages.
• Patients and residents benefit from the company's focus on expanding operations and improving quality of care, but regulatory changes and increased scrutiny on SNFs could affect service availability or quality.
• Customers (referral sources, managed care organizations) are impacted by the company's efforts to strengthen partnerships and expand its Medicare Advantage market share, potentially leading to broader service offerings.
• Suppliers and creditors are affected by the company's significant capital expenditures for acquisitions and renovations, indicating continued investment and business activity.
• Regulatory bodies and governmental agencies are actively scrutinizing the company's operations through audits and investigations, potentially leading to fines, penalties, or changes in compliance requirements.

Next Steps

• Continue to monitor and evaluate the impact of the One Big Beautiful Bill (OBBB) on Medicaid reimbursement mechanisms and enrollment dynamics.
• Actively evaluate the 2026 Medicare Physician Fee Schedule (PFS) Proposed Rule to understand its potential effects on operations and financial outcomes.
• Monitor the implementation of CMS's Interoperability Final Rule and its implications for data sharing and potential scrutiny.
• Continue to cooperate with the DOJ in response to the Civil Investigative Demand (CID) regarding Medicare and Texas Medicaid claims.
• Proceed with the appeal of the jury verdict in the Arizona medical negligence trial.
• Monitor the California Office of Health Care Affordability (OHCA) Cost and Market Impact Review (CMIR) and respond to the investigatory subpoena.
• Continue to implement the new enterprise resource planning (ERP) system, managing associated complexities and risks.
• Continue to pursue opportunistic and strategic acquisitions of facilities and businesses consistent with geographic, financial, and operating objectives.
• Monitor the impact of the federal government shutdown on Medicare and Medicaid payments and administrative processes.

Key Dates

Recommendation

The Ensign Group, Inc. demonstrates robust financial health and strategic growth, evidenced by significant increases in revenue, net income, and EPS for both the quarter and year-to-date periods. Operational metrics like occupancy and skilled mix are improving across its facilities, including newly acquired and transitioning ones. The company's aggressive expansion strategy, including entering new states and leveraging its captive REIT, positions it for continued market share gains. While the healthcare industry faces substantial regulatory and litigation risks, the company has a proven track record of navigating these challenges and actively manages its compliance and legal exposures. The ongoing stock repurchase programs signal management's confidence in the company's valuation. For a seasoned investor with an understanding of the inherent risks in the post-acute care sector, the strong performance and clear growth trajectory make ENSG an attractive investment.

Keywords

Skilled Nursing, Senior Living, Healthcare REIT, Post-Acute Care, SEC Filing, 10-Q, ENSG, Standard Bearer, Medicare, Medicaid, Occupancy, Acquisitions, Financial Results, Regulatory Risk, Litigation, Stock Repurchase